FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | 35.21% | -78.46% | -19.24% | -23.21% | 23.41% |
| Total Depreciation and Amortization | -5.17% | -8.11% | -15.28% | -9.16% | 9.18% |
| Total Amortization of Deferred Charges | 46.99% | 242.85% | 780.55% | 878.84% | 1,051.80% |
| Total Other Non-Cash Items | -78.05% | 72.66% | 40.19% | 118.84% | -20.41% |
| Change in Net Operating Assets | 164.53% | -17.00% | -23.46% | -69.50% | -54.12% |
| Cash from Operations | 67.12% | 20.18% | 16.65% | -0.30% | 19.41% |
| Capital Expenditure | 80.60% | -- | -- | -458.33% | -3.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | 100.00% | -83.55% |
| Cash from Investing | -104.44% | -122.22% | -122.22% | 95.89% | -86.20% |
| Total Debt Issued | -78.33% | -87.41% | 15.94% | 44.64% | 60.97% |
| Total Debt Repaid | 79.59% | 82.95% | -1,271.43% | -1,271.43% | -1,860.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.25% | 113.00% | 33.84% | -32.46% | -31.31% |
| Cash from Financing | -77.10% | -86.20% | 1.79% | 19.94% | 21.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -787.86% | -202.60% | 721.73% | 92.91% | 104.34% |